SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001370368-24-000007
Filing Date
2024-01-31
Accepted
2024-01-31 07:43:49
Documents
5
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 6-K a240131-6k.htm 6-K 15722
2 99.1 FINANCIAL REPORT Q4 2023 a240131-99_1.htm EX-99 300246
3 99.2 INTERIM FINANCIAL REPORT a240131-99_2.htm EX-99 1685971
4 IMAGE logo.jpg GRAPHIC 26773
5 IMAGE coverifr.jpg GRAPHIC 117726
  Complete submission text file 0001370368-24-000007.txt   2190459
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 24580648
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)